Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sale of France Workwear

28th May 2025 07:00

RNS Number : 3135K
Rentokil Initial PLC
28 May 2025
 

 

28th May 2025

RENTOKIL INITIAL PLC

 

Sale of France Workwear

 

Rentokil Initial plc (the "Group") is pleased to announce that it has entered into an agreement for the intended sale of its Workwear business in France with H.I.G. Capital (the "Proposed Transaction"). France Workwear comprises Rentokil Initial's workwear, flat linen and clean room business in France. As is common in France, a binding put option has been signed by H.I.G. Capital, committing it to complete the Proposed Transaction once mandatory information and consultation procedures with the French employee representative bodies and customary regulatory approvals have been satisfied.

 

The Proposed Transaction values France Workwear at a gross enterprise value of approximately €410m (c.$465m) on a cash-free debt-free basis including an earn-out mechanism with a maximum value of €30m (c.$34m) linked to the performance of the business in 2026. Total net cash proceeds are expected to be approximately €370m (c.$420m), subject to customary closing adjustments and the final earn-out outcome. Completion is expected to occur in Q4 2025.

 

The Proposed Transaction positions Rentokil Initial more clearly as a streamlined Pest and Hygiene & Wellbeing business, enabling the Group to effectively concentrate resources to better capitalise on the large, attractive long-term growth markets within these core areas. The sale of France Workwear results in a business with revenue comprising c.80% Pest and c.20% Hygiene & Wellbeing.

 

In addition, the Proposed Transaction should enhance the Group's capital efficiency through a meaningful reduction in capital expenditure requirements and improved cash flow, with a benefit to the free cash conversion percentage of approximately 100 basis points.

 

In-line with Rentokil Initial's balanced capital allocation model, the net proceeds would be used for general corporate purposes including deleveraging the balance sheet while continuing to invest in the core business organically, as well as investing for growth through bolt-on M&A.

 

Andy Ransom, Chief Executive of Rentokil Initial plc, said:

 

"This transaction is a further important step in the execution of our strategy to focus the company on Pest Control and Hygiene & Wellbeing, where we are a market leader. Over recent years we have been reshaping our portfolio towards higher growth markets and lower capital expenditure operations. In 2015, Pest Control accounted for just 44% of Group Revenue, today it's above 80%. This simplifies our business, strengthens our balance sheet, and enhances cash generation."

 

"This is a win-win deal which will provide additional focus and support for France Workwear as a standalone business, while Rentokil Initial continues to focus on the range of growth opportunities in Pest Control and Hygiene & Wellbeing over the short, medium and longer term."

 

Goldman Sachs International is acting as sole financial advisor and joint corporate broker to Rentokil Initial plc.

 

Note

 

In FY 2024, France Workwear, including flat linen textile and clean room business, generated Revenue of $324m, Adjusted Operating Profit of $57m and had associated capital expenditure of $93m.

 

 

Enquiries:

 

Investors / Analysts: Peter Russell, Rentokil Initial plc, + 44 7795 166506. Morenike Ogunseye, Rentokil Initial plc, +44 7818 883094

 

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEEEEWEISELI

Related Shares:

Rentokil Initial
FTSE 100 Latest
Value8,787.02
Change12.76